Winnipeg, MB – June 22, 2020 – Careica Health (Careica) is pleased to announce an agreement with Brisbane, Australia based Oventus Medical, an innovator in obstructive sleep apnea treatment. The agreement extends Careica’s well known sleep program to include the O2Vent Optima oral appliance, an alternative for OSA sufferers who are intolerant to CPAP therapy.
Under the agreement, clients will be serviced by the initial four lab-in-lab sites in Winnipeg, Regina, Calgary, and Edmonton with service expanding across western Canada in the coming months.
Cory McArthur, Careica’s President and CEO commented, “We are excited about the partnership with Oventus as we believe there is considerable opportunity to expand our sleep portfolio to include professionally fit oral sleep treatment. The precise way in which O2Vent Optima devices fit patients means we expect a very low number of product adjustment requests which should enable a smooth and efficient delivery of service through the Oventus telemedicine model.”
Dr. Chris Hart, founder and CEO of Oventus commented, “Careica has been operating a successful respiratory business for more than 30 years. Oventus is proud that such a well-respected Canadian sleep group has chosen to augment their existing sleep offering by adopting our treatment platform. As COVID-19 restrictions start to lift in Canada, we currently expect to see the four lab-in-lab sites deployed by mid-summer.”
About Careica Health
Over the past 30 years, Careica Health has established itself as a leader in respiratory care, employing over 230 people, in 26 offices across western Canada. Careica focuses on creating innovative respiratory care programs that support sufferers of sleep disordered breathing and respiratory disease. With a focus on life-long care and support, clients experience a new standard of comfort, mobility and freedom.
For media inquiries please contact:
Director, Marketing & Business Development
For a PDF copy of this release, click here.